T-900607
N/A
Report date: 2022/11/25 17:43:25
NME
Base Information
Drug NameT-900607
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[6]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAmgen Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesNational Cancer InstituteTularik Inc
Active IndicationsN/A
Inactive Indications +[6]
Other Information
ATC CodeN/A
Related LinksN/A